Cevimeline
Pharmaceutical drug / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Cevimeline?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Cevimeline (trade name Evoxac) is a synthetic analog of the natural alkaloid muscarine with a particular agonistic effect on M1 and M3 receptors. It is used in the treatment of dry mouth and Sjögren's syndrome.
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Evoxac |
AHFS/Drugs.com | Monograph |
MedlinePlus | a608025 |
Pregnancy category |
|
Routes of administration | By mouth (capsules) |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | <20% |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H17NOS |
Molar mass | 199.31 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close